151 related articles for article (PubMed ID: 30154486)
1. Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Hochmann S; Mittermeir M; Santic R; Koszik F; Griessner L; Sonderegger AS; Hoffmann T; Russe E; Scheiblhofer S; Weiss R; Mandler M; Schneeberger A; Strunk D
Sci Rep; 2018 Aug; 8(1):12954. PubMed ID: 30154486
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha.
Rodríguez-Villanueva J; McDonnell TJ
Int J Cancer; 1995 Mar; 61(1):110-4. PubMed ID: 7705922
[TBL] [Abstract][Full Text] [Related]
3. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
[TBL] [Abstract][Full Text] [Related]
4. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of interferon-alpha transcription defects in malignant melanoma.
Price KL; Herlyn M; Dent CL; Gewert DR; Linge C
Melanoma Res; 2005 Apr; 15(2):91-8. PubMed ID: 15846141
[TBL] [Abstract][Full Text] [Related]
6. Interferon system defects in human malignant melanoma.
Linge C; Gewert D; Rossmann C; Bishop JA; Crowe JS
Cancer Res; 1995 Sep; 55(18):4099-104. PubMed ID: 7664286
[TBL] [Abstract][Full Text] [Related]
7. Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.
Kirkwood JM; Farkas DL; Chakraborty A; Dyer KF; Tweardy DJ; Abernethy JL; Edington HD; Donnelly SS; Becker D
Mol Med; 1999 Jan; 5(1):11-20. PubMed ID: 10072444
[TBL] [Abstract][Full Text] [Related]
8. Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
Maellaro E; Pacenti L; Del Bello B; Valentini MA; Mangiavacchi P; De Felice C; Rubegni P; Luzi P; Miracco C
Br J Dermatol; 2003 Jun; 148(6):1115-24. PubMed ID: 12828737
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
10. Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion.
Wang J; Murakami T; Hakamata Y; Ajiki T; Jinbu Y; Akasaka Y; Ohtsuki M; Nakagawa H; Kobayashi E
Cancer Gene Ther; 2001 Oct; 8(10):705-12. PubMed ID: 11687893
[TBL] [Abstract][Full Text] [Related]
11. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to extrinsically supplied interferon and the endogenous expression of interferon in melanoma cell lines.
Hanson C; Köpf I; Weijdegård B; Weimarck A; Stierner U
Melanoma Res; 1999 Oct; 9(5):451-6. PubMed ID: 10596911
[TBL] [Abstract][Full Text] [Related]
13. Double-stranded secondary structures on mRNA induce type I interferon (IFN alpha/beta) production and maturation of mRNA-transfected monocyte-derived dendritic cells.
Ceppi M; Ruggli N; Tache V; Gerber H; McCullough KC; Summerfield A
J Gene Med; 2005 Apr; 7(4):452-65. PubMed ID: 15515120
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.
Wilgenhof S; Van Nuffel AM; Corthals J; Heirman C; Tuyaerts S; Benteyn D; De Coninck A; Van Riet I; Verfaillie G; Vandeloo J; Bonehill A; Thielemans K; Neyns B
J Immunother; 2011 Jun; 34(5):448-56. PubMed ID: 21577140
[TBL] [Abstract][Full Text] [Related]
15. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
[TBL] [Abstract][Full Text] [Related]
16. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis.
McCarty MF; Bielenberg DR; Nilsson MB; Gershenwald JE; Barnhill RL; Ahearne P; Bucana CD; Fidler IJ
Melanoma Res; 2003 Aug; 13(4):379-87. PubMed ID: 12883364
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma downregulates epidermal growth factor receptors on human melanoma cells.
Worm M; Makki A; Dippel E; Czarnetzki BM; Schadendorf D
Exp Dermatol; 1995 Feb; 4(1):30-5. PubMed ID: 7757329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
19. A regulatory domain within the virus-response element of the interferon alpha 1 gene acts as a transcriptional repressor sequence and determinant of cell-specific gene expression.
Dent CL; Gewert DR
Eur J Biochem; 1996 Mar; 236(3):895-903. PubMed ID: 8665911
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Mitchell MS; Abrams J; Thompson JA; Kashani-Sabet M; DeConti RC; Hwu WJ; Atkins MB; Whitman E; Ernstoff MS; Haluska FG; Jakowatz JG; Das Gupta TK; Richards JM; Samlowski WE; Costanzi JJ; Aronson FR; Deisseroth AB; Dudek AZ; Jones VE
J Clin Oncol; 2007 May; 25(15):2078-85. PubMed ID: 17513813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
